Alvaro Laureano
Overview
Explore the profile of Alvaro Laureano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kennis B, Michel K, Brugmann W, Laureano A, Tao R, Somanchi S, et al.
J Neurooncol
. 2019 Apr;
142(3):409.
PMID: 30968268
There was a typo in author Andrew Wahba's name in the initial online publication. The original article has been corrected.
2.
Kennis B, Michel K, Brugmann W, Laureano A, Tao R, Somanchi S, et al.
J Neurooncol
. 2019 Feb;
142(3):395-407.
PMID: 30788681
Purpose: Medulloblastoma (MB) is the most common malignant brain tumor in children. Recent studies have shown the ability of natural killer (NK) cells to lyse MB cell lines in vitro,...
3.
Carvalho T, Pellenz F, Laureano A, da Rocha Silla L, Giugliani R, Baldo G, et al.
Biotechnol Lett
. 2018 Jan;
40(3):617-622.
PMID: 29344849
Objectives And Results: Mesenchymal stromal cells (MSCs) are potential targets for cell and gene therapy-based approaches against a variety of different diseases. The MSCs from bone marrow are a promising...
4.
Pezzi A, Amorin B, Laureano A, Valim V, Dahmer A, Zambonato B, et al.
J Cell Biochem
. 2017 Feb;
118(10):3072-3079.
PMID: 28240374
Mesenchymal stem cells (MSC) are considered multipotent stromal, non-hematopoietic cells with properties of self-renovation and differentiation. Optimal conditions for culture of MSC have been under investigation. The oxygen tension used...
5.
Pitombeira B, Paz A, Pezzi A, Amorin B, Valim V, Laureano A, et al.
Bone Marrow Res
. 2014 Jan;
2013:565824.
PMID: 24416593
Background. Allogeneic hematopoietic stem cell transplantation (HSCT) is still associated with a high transplant-related mortality rate. In 2009, the EBMT risk score was validated as a simple tool to predict...
6.
Taylor P, Fangusaro J, Rajaram V, Goldman S, Helenowski I, MacDonald T, et al.
Mol Cancer Ther
. 2012 Aug;
11(8):1713-1723.
PMID: 22848092
Medulloblastoma is a malignant pediatric brain tumor. Current treatment following patient stratification into standard and high-risk groups using clinical features has improved survival. However, a subset of patients with standard...